TrialDiabetes care2021

Switching to Once-Weekly Insulin Icodec Versus Once-Daily Insulin Glargine U100 in Type 2 Diabetes Inadequately Controlled on Daily Basal Insulin: A Phase 2 Randomized Controlled Trial.

Harpreet S Bajaj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.